1Gan TJ, Ginsberg B, Glass PSA, et al. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology, 1997, 87:1075～1081.
2Crain SM, Shen KF. Antagonists of excitatory opioid recepto r functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability.Pain, 2000, 84:121～131.
3Kurashi Y, Sugimoto M, Hamada T, et al. Noxious stimuli and met-enkephalin release from nucleus reticularis gigantocelluralis. Brain Research Bulletin, 1984, 72: 123～127.
4Paronis CA, Holtzman SG. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. J Pharmacol Exp Ther, 1991,259:582～589.
7Gan TJ ,Ginsberg B, Glass PSA, et al. Opioid-sparing effects of a lowdose infusion of naloxone in patient-administered morphine sulfate[J].Anesthesiology, 1997,87(5) : 1075-1081.
8[1]Lee J, Shim JY, Choi JH, et al. Epidural naloxone reduces intestinal hypomotility but not analgesia of epidural morphine. Can J Anaesth, 2001,48:54 ～ 58.
9[4]Ueda H, Fukushima N, Kitao T, et al. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neurosci Lett, 1986,65: 247 ～252.
